| Device |
reagents, monkeypox virus nucleic acid. |
| Definition |
Nucleic acid-based in vitro diagnostic devices for the detection of monkeypox virus and/or diagnosis of Monkeypox in human clinical specimens |
| Physical State |
In Vitro Diagnostic Device including Primers, Probes and/or capture oligos |
| Technical Method |
Nucleic acid amplification and/or detection |
| Target Area |
The device is an in-vitro diagnostic device used on clinical specimens; none of the body parts will utilize the device or are intended to be affected by the device. |
| Review Panel |
Microbiology |
| Product Code | QTP |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Microbiology Devices
(DMD)
|
|
Not Classified Reason
|
EUA - Emergency Use Authorization
|
| Submission Type |
EUA - Emergency Use Authorization
|
| Device Class |
Not Classified
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |